Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-alpha treatment response in rheumatoid arthritis.

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

8 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Rheumatology International
DOIs	https://doi.org/10.1007/s00296-009-0978-4
Publikationsstatus	Veröffentlicht - 2010

Wissenschaftszweige

@article{4b7239506dc14b7bad8194ddb3d31612,

title = "Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-alpha treatment response in rheumatoid arthritis.",

author = "Christian Dejaco and C Duftner and W Klotz and M Schirmer and M Herold",

year = "2010",

doi = "10.1007/s00296-009-0978-4",

language = "English",

journal = "Rheumatology International",

issn = "0172-8172",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-alpha treatment response in rheumatoid arthritis.

AU - Duftner, C

AU - Klotz, W

AU - Schirmer, M

AU - Herold, M

A2 - Dejaco, Christian

PY - 2010

Y1 - 2010

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000273854500004

UR - https://pubmed.ncbi.nlm.nih.gov/19506882

U2 - 10.1007/s00296-009-0978-4

DO - 10.1007/s00296-009-0978-4

M3 - Research article

C2 - 19506882

SN - 0172-8172

JO - Rheumatology International

JF - Rheumatology International

ER -